TCR V γ 3 Activators
TCR V γ 3 Activators encompass a range of chemical compounds that indirectly enhance the functional activity of the protein through intricate signaling networks. For example, PMA and Ionomycin manipulate intracellular signaling molecules such as PKC and calcium, respectively; both are crucial for the downstream signaling events following TCR engagement, thus indirectly promoting the activation of TCR V γ 3.
Similarly, the modulation of intracellular cAMP levels through Forskolin can also affect TCR signaling cascades, leading to an enhanced response by TCRGiven the constraints of the task and the absence of explicit chemical activators for TCR V γ 3 (T Cell Receptor V gamma 3), the list will include compounds that can logically be expected to influence the signaling pathways or cellular processes in which TCR V γ 3 is directly involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a diacylglycerol analog to activate protein kinase C (PKC), which can enhance TCR signaling cascades. PKC is known to phosphorylate key proteins within the TCR complex, leading to the amplification of signal transduction. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin functions as a calcium ionophore, raising intracellular calcium levels and potentiating the signaling pathways downstream of TCR engagement that require calcium as a second messenger. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, preventing the dephosphorylation and activation of the nuclear factor of activated T-cells (NFAT), a key transcription factor in T cells. This can indirectly affect TCR V γ 3 signaling by altering the cellular context in which TCR signaling occurs. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of serine/threonine phosphatases, and its action can lead to the enhanced phosphorylation of proteins involved in TCR signaling, potentially influencing the activity of TCR V γ 3. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of PKC, and by inhibiting certain PKC isoforms, it may shift the balance of TCR signaling through alternate pathways that enhance TCR V γ 3 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylate cyclase, increasing intracellular cAMP levels, which can modulate TCR signaling through PKA activation and downstream effects on the TCR complex. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and by dampening PI3K/Akt signaling, it can affect TCR signaling. This can lead to a compensatory upregulation of other signaling molecules in T cells that may enhance TCR V γ 3 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in T cell activation and proliferation. Inhibition of mTOR can lead to alterations in T cell signaling pathways that promote TCR V γ 3 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that can non-selectively inhibit kinases involved in TCR signaling, potentially influencing TCR V γ 3 activation due to the complex interplay of kinases in signal transduction. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor that would affect the initiation of TCR signaling. As Src kinases are critical for TCR activation, altering their activity can indirectly influence the functional activity of TCR V γ 3. | ||||||